Mg. Vannucchi et G. Pepeu, MUSCARINIC RECEPTOR MODULATION OF ACETYLCHOLINE-RELEASE FROM RAT CEREBRAL-CORTEX AND HIPPOCAMPUS, Neuroscience letters, 190(1), 1995, pp. 53-56
An attempt to identify the muscarinic receptor subtypes involved in pr
esynaptic modulation of acetylcholine (ACh) release from cortical and
hippocampal slices was made by means of several muscarinic antagonists
. Cortical and hippocampal slices prepared from adult rats were superf
used with Krebs solution containing physostigmine; ACh content of the
superfusate at rest and after electrical stimulation (I Hz) was quanti
fied by high performance liquid chromatography. The antagonists were a
dded to the Krebs at the concentration of 1 mu M. ACh release at rest
was enhanced only in the cortex by rbonyl}-6H-pyrido[2,3-b](1,4)-benzo
diazepine-6-one (AFDX384), an M2/M4 selective antagonist. The evoked A
Ch release from the cerebral cortex was significantly increased by AFD
X384, methoctramine, pirenzepine, M2/M4, M2 and M1 selective antagonis
ts, respectively, and scopolamine. This finding suggests that M1, M2 a
nd M4 presynaptic receptor subtypes could regulate evoked ACh release
in the cortex. In hippocampal slices, the evoked ACh release was enhan
ced by AFDX384, pirenzepine and scopolamine but not by methoctramine.
In this region ACh release seems therefore regulated only by M1 and M4
receptor subtypes. The M3 antagonist (+/-)-p-fluorohexahydro-sila-dif
enidol hydrochloride did not affect ACh release.